ArticleMovement disorders clinical practice2025

Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Parkinson's Disease: Real-World Short-Term Data on Tolerability, Infusion Rate Adjustments and Concomitant Medication.

Katarina Rukavina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.